Trials / Unknown
UnknownNCT03321461
TMTP1-ICG Mapping in Colposcopy-directed Biopsy
Novel Tumor Targeted Fluorescent TMTP1-ICG Mapping in Colposcopy-directed Biopsy
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Investigators aimed to determine the validity of the novel tumor targeted fluorescent TMTP1-ICG to increased accuracy of colposcopy-directed biopsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TMTP1 | Fluorescent sites will be removed |
| DRUG | ICG | Fluorescent sites will be removed |
Timeline
- Start date
- 2017-11-01
- Primary completion
- 2020-08-31
- Completion
- 2021-12-01
- First posted
- 2017-10-25
- Last updated
- 2021-06-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03321461. Inclusion in this directory is not an endorsement.